3 million diabetes glucose monitors recalled after 7 deaths and over 700 injuries

Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate readings.

The U.S. Food and Drug Administration announced Dec. 2 that Abbott issued a warning for some sensors in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices. Internal testing by the company found the sensors could malfunction and provide incorrect low glucose readings.

The recall affects approximately 3 million sensors in the U.S. from a single production line, though Abbott estimates about half have already been used or expired. No other Libre products are impacted.

Abbott reported receiving 736 “severe adverse events” possibly linked to the monitors, including 57 in the U.S.